Moderna, Inc. (FRA:0QF)
21.00
-0.81 (-3.71%)
Dec 1, 2025, 8:26 PM CET
Moderna Revenue
Moderna had revenue of $1.02B USD in the quarter ending September 30, 2025, a decrease of -45.44%. This brings the company's revenue in the last twelve months to $2.23B, down -56.07% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$2.23B
Revenue Growth
-56.07%
P/S Ratio
4.27
Revenue / Employee
$384.83K
Employees
5,800
Market Cap
8.12B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Moderna News
- 13 hours ago - What's Going On With Moderna Stock Monday? - Benzinga
- 14 hours ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 14 hours ago - Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More - Investopedia
- 14 hours ago - Moderna (MRNA) Shares Drop Amid Stricter FDA Vaccine Approval Standards - GuruFocus
- 15 hours ago - Moderna, vaccine makers decline following FDA official comments on future approvals - Seeking Alpha
- 16 hours ago - Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths - Investor's Business Daily
- 16 hours ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons
- 18 hours ago - Stocks making the biggest moves premarket: Synopsys, Moderna, Micron Technology, Wynn Resorts, Coinbase and more - CNBC